NCT03006848 A Phase II Trial of Avelumab in Patients With Recurrent or Progressive Osteosarcoma Status COMPLETED Phase PHASE2
NCT03004859 Opportunistic Screening in Pharmacies for Atrial Fibrillation in Seniors (>65 Years) Status COMPLETED Phase N/A
NCT03002740 Bleeding Events and Oral Anticoagulant Treatment in Non-Valvular Atrial Fibrillation Status WITHDRAWN Phase N/A
NCT03000439 A Safety, Efficacy And Pharmacokinetics Study Of Tofacitinib In Pediatric Patients With sJIA Status COMPLETED Phase PHASE3
NCT02997176 An Open-Label Pharmacokinetics and Safety Study of Talazoparib (MDV3800) Status COMPLETED Phase PHASE1
NCT02997163 An Open-Label Pharmacokinetics and Safety Study of Talazoparib Status COMPLETED Phase PHASE1
NCT02996500 Safety and Efficacy of Pf-06650833 In Subjects With Rheumatoid Arthritis, With An Inadequate Response To Methotrexate Status COMPLETED Phase PHASE2
NCT02981472 A Study of the Safety and Pharmacokinetics of Apixaban Versus Vitamin K Antagonist (VKA) or Low Molecular Weight Heparin (LMWH) in Pediatric Subjects With Congenital or Acquired Heart Disease Requiring Anticoagulation Status COMPLETED Phase PHASE2
NCT02974868 Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Subjects With Alopecia Areata Status COMPLETED Phase PHASE2
NCT02974374 Single Dose of PF-06835919 Escalation Study in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT02969044 Study To Assess The Efficacy And Safety Of Pf-06651600 In Subjects With Rheumatoid Arthritis With An Inadequate Response To Methotrexate Status COMPLETED Phase PHASE2
NCT02969018 Study To Evaluate Safety And Efficacy Of PF-06700841 In Subjects With Moderate To Severe Plaque Psoriasis Status COMPLETED Phase PHASE2
NCT02960022 A Study for Subjects With Prostate Cancer Who Previously Participated in an Enzalutamide Clinical Study Status RECRUITING Phase PHASE2
NCT02958865 Study to Compare Oral PF-06651600, PF-06700841 and Placebo in Subjects With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT02956967 Home Administration of NivestimTM in the Primary Prophylaxis of Chemotherapy-Induced Febrile Neutropenia Status COMPLETED Phase N/A
NCT02955160 A Phase 1, Randomized, Controlled, Observer-blinded Trial to Evaluate the Safety and Immunogenicity of a Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults Aged 18 to 49 Years Status COMPLETED Phase PHASE1